Literature DB >> 17425387

Ensuring timely completion of type and screen testing and the verification of ABO/Rh status for elective surgical patients.

Sunita Saxena1, Janice M Nelson, Melanie Osby, Mrugesh Shah, Raymond Kempf, Ira A Shulman.   

Abstract

CONTEXT: A blood bank can provide compatible blood for an elective surgical procedure, provided a blood sample is received by the laboratory with sufficient time to allow pretransfusion testing and acquire enough compatible red blood cell units. With the push for same-day admission surgical procedures, a patient's pretransfusion blood sample is often collected the morning of surgery. However, if blood is needed, compatible units might not be immediately available.
OBJECTIVE: To define and improve the process of completing presurgical/preadmission type and screen testing and verifying the ABO/Rh status of scheduled surgical patients before they receive a transfusion. STUDY
DESIGN: A list of surgical procedures that might necessitate blood transfusion was created. A checklist was used to ensure that the preoperative clinic nurse collects a baseline pretransfusion blood sample for type and screen testing from patients scheduled for a listed procedure. A new pretransfusion specimen was received on the day of surgery, if needed, so that a current specimen would be available for compatibility testing and to verify the accuracy of the patient's ABO/Rh status in case blood was requested.
RESULTS: During the 1-year study period, 666 patients qualified for baseline type and screen testing. Cholecystectomy was the most commonly scheduled surgery. In 99% of cases, a baseline type and screen specimen was received in the laboratory at least 1 day before surgery. The interval between the preoperative clinic visit and date of surgery varied from same day (6 patients) to 3 months.
CONCLUSION: Timely receipt of a presurgical specimen for type and screen testing and verification of a patient's ABO/Rh status can be ensured when clinical services collaborate and when the hospital blood utilization committee provides oversight to improve compliance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17425387     DOI: 10.5858/2007-131-576-ETCOTA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Development of a risk prediction model for transfusion in carotid endarterectomy and demonstration of cost-saving potential by avoidance of "type and screen".

Authors:  Lars Stangenberg; Thomas Curran; Fahad Shuja; Robert Rosenberg; Feroze Mahmood; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-07-16       Impact factor: 4.268

2.  Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

3.  Prevention of surgical delays by pre-admission type and screen in patients with scheduled surgical procedures: improved efficiency.

Authors:  Zhengtong Pei; Arpad Szallasi
Journal:  Blood Transfus       Date:  2014-10-29       Impact factor: 3.443

4.  Routine preoperative typing and screening: a safeguard or a misuse of resources.

Authors:  Silvio Fabian Ghirardo; Ishwaria Mohan; Alicia Gomensoro; Mitchell I Chorost
Journal:  JSLS       Date:  2010 Jul-Sep       Impact factor: 2.172

5.  Evaluation of Alloimmunization Rate and Necessity of Blood Type and Screening Test among Patients Candidate for Elective Surgery.

Authors:  Ahmad Gharehbaghian; Behrooz Ghezelbash; Sima Aghazade; Mohammad Taher Hojjati
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

6.  The Utility of ABO Testing in Pediatric Patients Undergoing Elective Surgery.

Authors:  Min Seob Kim; Sanghyun Ahn; Eun-Jin Chung; Seungeun Choi; Jin-Tae Kim; Ho-Geol Ryu
Journal:  J Clin Med       Date:  2019-09-02       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.